CooperCompanies Announces Release Date for First Quarter 2021
CooperCompanies (NYSE: COO) will announce its first quarter 2021 financial results on March 4, 2021, at 4:15 PM ET. Following the announcement, a conference call will take place at 5:00 PM ET to discuss the financial results and recent developments. The conference call can be accessed by dialing 855-643-4430 in the U.S. or 707-294-1332 internationally, with the passcode 'Cooper'. A replay of the call will be available until March 11, 2021. CooperCompanies operates in vision care and women's health, with a global workforce exceeding 12,000.
- Scheduled release of Q1 2021 financial results, potentially positive for investor sentiment.
- Live conference call provides direct engagement with investors for Q&A.
- None.
SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 8:00 PM ET on March 4, 2021 through March 11, 2021. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 266737.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies announce its financial results?
What time is the conference call for CooperCompanies' Q1 results?
How can I listen to the CooperCompanies conference call?
Will the conference call be available for replay?